Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qinling granules for hyperuricemia (damp-heat retention pattern) – randomized double-blind placebo-controlled phase II trial
CTR20250607Phase 2Active
- Sponsor
- NewVipero
- Start
- Feb 2025
- Countries
- 1
01
Overview
A Phase 2 trial of Qinling Granules in hyperuricemia, sponsored by NewVipero. Started Feb 2025; status: active.
02
Drugs
Qinling Granules
03
Conditions
hyperuricemia
Beyond the preview
Go deeper on CTR20250607.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20250607.